Phospho-Histone H3 (Ser10) AntibodyProduct information
Phospho-Histone H3 (Ser10) Antibody
|100 µl (10 western blots)||
Phospho-Histone H3 (Ser10) Antibody
|300 µl (30 western blots)||
Product Pathways - Chromatin Regulation / Epigenetics
Phospho-Histone H3 (Ser10) Antibody #9701
|9701L||300 µl (30 western blots)||---||In Stock||---|
|9701S||100 µl (10 western blots)||---||In Stock||---|
|9701||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse, Rat, Monkey, D. melanogaster, S. cerevisiae||Endogenous||17||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IHC-P=Immunohistochemistry (Paraffin), IHC-F=Immunohistochemistry (Frozen), IF-IC=Immunofluorescence (Immunocytochemistry), F=Flow Cytometry
Species predicted to react based on 100% sequence homology: Xenopus.
Specificity / Sensitivity
Phospho-Histone H3 (Ser10) Antibody detects endogenous levels of histone H3 only when phosphorylated at Ser10; however, this antibody does not detect phosphorylated Ser10 when Lys9 is acetylated or methylated. This antibody does not cross-react with histone H3 phosphorylated at Ser28.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser10 of human histone H3. Antibodies are purified by protein A and peptide affinity chromatography.
Western blot analysis of whole cell lysates of NIH/3T3 cells, untreated, treated with TSA (to induce histone acetylation), serum plus calyculin A (to induce phosphorylation of H3) or both, using Phospho-Histone H3 (Ser10) Antibody.
Immunohistochemical staining of phosphorylated histone H3 in paraffin-embedded human breast carcinoma showing nuclear localization using Phospho-Histone H3 (Ser10) Antibody.
Immunohistochemical analysis of HT29 cells using Phospho-Histone H3 (Ser10) Antibody. Note the specific staining of mitotic cells.
Immunohistochemical analysis of paraffin-embedded human colon carcinoma, untreated (left) or lambda phosphatase-treated (right), using Phospho-Histone H3 (Ser10) Antibody.
Immunohistochemical analysis of paraffin-embedded human tonsil using Phospho-Histone H3 (Ser10) Antibody.
Immunohistochemical analysis of paraffin-embedded 4T1 syngeneic mouse tumor using Phospho-Histone H3 (Ser10) Antibody #9701.
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using Phospho-Histone H3 (Ser10) Antibody in the presence of control peptide (left) or Phospho-Histone H3 (Ser10) Blocking Peptide #1000 (right).
Immunohistochemical analysis of frozen H1650 xenograft, showing staining of mitotic cells using Phospho-Histone H3 (Ser10) Antibody.
Confocal microscopic image of a mitotic HeLa cell labeled with Phospho-Histone H3 (Ser10) Antibody (red) and Survivin (6E4) Mouse mAb #2802 (green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Flow cytometric analysis of untreated Jurkat cells, using Phospho-Histone H3 (Ser10) Antibody versus propidium iodide (DNA content). The box indicates phospho-histone H3 positive cells.
Flow cytometric analysis of Phospho-Histone H3 (Ser10) Antibody staining of untreated (blue) or serum/calyculin treated (green) Ramos cells compared to a nonspecific negative control antibody (red).
Peptide dot blot analysis demonstrating Phospho-Histone H3 (Ser10) Antibody #9701 antibody specificity. Antibody binding to pre-coated histone H3 peptides is shown using Phospho-Histone H3 (Ser10) (D7N8E) XP® Rabbit mAb #53348,
Phospho-Histone H3 (Ser10) (D2C8) XP® Rabbit mAb #3377, and Phospho-Histone H3 (Ser10) Antibody #9701. As shown, Phospho-Histone H3 (Ser10) Antibody #9701 detects histone H3 phosphorylated on Ser10; however, this antibody does not detect histone H3 phosphorylated on Ser10 when Lys9 is acetylated or methylated. In addition, this antibody does not cross-react with histone H3 phosphorylated on Ser28.
Modulation of chromatin structure plays an important role in the regulation of transcription in eukaryotes. The nucleosome, made up of DNA wound around eight core histone proteins (two each of H2A, H2B, H3, and H4), is the primary building block of chromatin (1). The amino-terminal tails of core histones undergo various post-translational modifications, including acetylation, phosphorylation, methylation, and ubiquitination (2-5). These modifications occur in response to various stimuli and have a direct effect on the accessibility of chromatin to transcription factors and, therefore, gene expression (6). In most species, histone H2B is primarily acetylated at Lys5, 12, 15, and 20 (4,7). Histone H3 is primarily acetylated at Lys9, 14, 18, 23, 27, and 56. Acetylation of H3 at Lys9 appears to have a dominant role in histone deposition and chromatin assembly in some organisms (2,3). Phosphorylation at Ser10, Ser28, and Thr11 of histone H3 is tightly correlated with chromosome condensation during both mitosis and meiosis (8-10). Phosphorylation at Thr3 of histone H3 is highly conserved among many species and is catalyzed by the kinase haspin. Immunostaining with phospho-specific antibodies in mammalian cells reveals mitotic phosphorylation at Thr3 of H3 in prophase and its dephosphorylation during anaphase (11).
- Workman, J.L. and Kingston, R.E. (1998) Annu Rev Biochem 67, 545-79.
- Hansen, J.C. et al. (1998) Biochemistry 37, 17637-41.
- Strahl, B.D. and Allis, C.D. (2000) Nature 403, 41-5.
- Cheung, P. et al. (2000) Cell 103, 263-71.
- Bernstein, B.E. and Schreiber, S.L. (2002) Chem Biol 9, 1167-73.
- Jaskelioff, M. and Peterson, C.L. (2003) Nat Cell Biol 5, 395-9.
- Thorne, A.W. et al. (1990) Eur J Biochem 193, 701-13.
- Hendzel, M.J. et al. (1997) Chromosoma 106, 348-60.
- Goto, H. et al. (1999) J Biol Chem 274, 25543-9.
- Preuss, U. et al. (2003) Nucleic Acids Res 31, 878-85.
- Dai, J. et al. (2005) Genes Dev 19, 472-88.
- Idikio, H.A. (2006) Anticancer Res 26, 4687-94.
- Li, J. et al. (2001) Mol. Cell. Biol. 21 (23), 8213-8224. Applications: IC-IF, Western Blotting.
- Allison, S.J. and Milner, J. (2003) Cancer Res. 63, 6674-6679. Applications: Western Blotting.
- Li, T. et al. (2004) Mol. Cell. Biol. 24, 3188-3197. Applications: IC-IF.
- Sugiyama, K. et al. (2002) Oncogene 21, 3103-3111. Applications: Western Blotting.
- Song, N. et al. (2011) Acta Histochem Cytochem 44, 183-90. Applications: IHC-P (paraffin).
- Cheung, C.H. et al. (2011) PLoS One 6, e23485. Applications: IF-P (paraffin), Western Blotting.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 9711 Acetyl- and Phospho-Histone H3 (Lys9/Ser10) Antibody
- 9441 Acetylated-Lysine Antibody
- 9681 Acetylated-Lysine Mouse mAb (Ac-K-103)
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 9717 Histone H3 (3H1) Rabbit mAb
- 4499 Histone H3 (D1H2) XP® Rabbit mAb
- 4620 Histone H3 (D2B12) XP® Rabbit mAb (ChIP Formulated)
- 9715 Histone H3 Antibody
- 2650 Histone H3 Antibody (ChIP Formulated)
- 3377 Phospho-Histone H3 (Ser10) (D2C8) XP® Rabbit mAb
- 53348 Phospho-Histone H3 (Ser10) (D7N8E) XP® Rabbit mAb
- 1000 Phospho-Histone H3 (Ser10) Blocking Peptide
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
- 8112 SignalStain® Antibody Diluent
- 8114 SignalStain® Boost IHC Detection Reagent (HRP, Rabbit)
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
DRAQ5 is a registered trademark of Biostatus Limited.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.